Viewing Study NCT02436538



Ignite Creation Date: 2024-05-06 @ 4:03 AM
Last Modification Date: 2024-10-26 @ 11:42 AM
Study NCT ID: NCT02436538
Status: COMPLETED
Last Update Posted: 2016-12-06
First Post: 2015-05-04

Brief Title: Correlation Between Serum Anti-Müllerian Hormone Müllerian Ducts Anomalies in Infertility
Sponsor: Ahmed MKamel
Organization: Kasr El Aini Hospital

Study Overview

Official Title: Correlation Between Serum Anti-Müllerian Hormone AMH Levels Müllerian Ducts Anomalies in Patients Undergoingintracytoplasmic Sperm Injection ICSI
Status: COMPLETED
Status Verified Date: 2016-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Anti-Müllerian hormone AMH also known as Müllerian inhibiting substance is a dimeric glycoprotein that belongs to the transforming growth factor-beta family It is involved in the regression of the Müllerian ducts during male fetal development In the female AMH is solely produced by the granulosa cells of preantral and small antral follicles and regulates ovarian activity and follicular steroidogenesis
Detailed Description: Following approval of the internal review board of Egyptian IVF-ET center a retrospective analysis will be undertaken where a detailed review of the patients files who underwent intracytoplasmic sperm injection ICSI trials starting January 2010 till January 2015 will be done

Patients with diagnosed mullerian anomalies will have their name age duration of infertility serum FSH LH AMH levels recorded The method of diagnosis HSG 3Dultrasonography hysteroscopy or laparoscopy will also be documented

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None